Consumer staples ETFs often come into focus when investors look to balance growth exposure with more defensive characteristics and reliable income. IYK, KXI, and XLP all target this space, yet each follows a different index, geographic scope, and fee structure. IYK brings U.S. exposure with an added healthcare component, KXI broadens the reach internationally, and XLP keeps things tightly focused on large U.S. staples names at a notably lower cost. In my view, grasping these differences helps clarify how each fund might behave across varying market conditions.
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index and typically holds 53–58 securities with a 0.37% expense ratio. Leading holdings include PG, KO, PM, and PEP, which together make up more than half the portfolio. One thing that stands out is its sector mix: while staples dominate, about 13% sits in healthcare names such as CVS and MCK, plus a modest basic-materials allocation. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry. This blend keeps IYK somewhat less pure than its peers, though it still maintains a defensive profile with beta below the broader market.
KXI follows the S&P Global 1200 Consumer Staples (Sector) Capped Index and holds 95–117 securities at a 0.38% expense ratio. Top positions feature WMT, COST, PG, KO, and PM, along with international names such as Nestlé, Unilever, and British American Tobacco. The U.S. accounts for roughly 60% of assets, with the rest spread across the U.K., Japan, Switzerland, France, and other markets. From what I see, the global reach introduces currency and demand factors that differ from purely domestic funds, even though the fee level aligns closely with IYK.
XLP tracks the Consumer Staples Select Sector Index and holds about 38 names at a low 0.08% expense ratio. Its largest positions mirror several of the others—WMT, COST, PG, KO, and PM—with additional names such as MDLZ, MO, CL, and TGT. The portfolio stays essentially 100% in consumer defensive names. Its substantial asset base and trading volume support tight spreads and strong liquidity, which I’m watching closely as a practical edge for larger or more frequent trades.
Consumer staples tend to attract attention during periods when growth slows, inflation pressures discretionary spending, or market volatility increases. Demand for essentials like food, beverages, and household products remains relatively steady, supporting consistent dividends. At the same time, the sector contends with currency movements for global companies, shifts toward private-label options, and regulatory focus on tobacco and packaged foods. GLP-1 weight-loss drugs have also prompted longer-term questions about consumption patterns. These dynamics help explain why staples have drawn defensive flows in recent cycles while still trailing high-growth areas in stronger risk-on environments.
The three funds have generally moved together in recent periods, yet structural distinctions create noticeable dispersion. XLP’s concentrated large-cap focus can amplify swings in a few mega-cap holdings, while IYK’s healthcare exposure sometimes moderates pure staples moves. KXI’s international component brings currency and overseas demand influences that can diverge from U.S.-only results. On fees, XLP’s 0.08% expense ratio provides a steady compounding advantage relative to the 0.37%–0.38% range of the iShares funds. Concentration risk sits highest with XLP and lowest with KXI, though IYK’s capped index helps limit single-stock dominance. These factors influence how each fund performs across different market regimes.
In my research process, I often turn to Tickeron’s AI Screener when comparing ETFs like these. The tool lets me apply filters for industry exposure, technical patterns, volatility, and performance metrics across thousands of securities, which helps surface relative positioning ideas more quickly than manual review. It has become a useful step for refining shortlists and spotting how funds such as IYK, KXI, and XLP align with broader sector trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows